Literature DB >> 20384295

Antiplasmodial lanostanes from the Ganoderma lucidum mushroom.

Michael Adams1, Marco Christen, Inken Plitzko, Stefanie Zimmermann, Reto Brun, Marcel Kaiser, Matthias Hamburger.   

Abstract

In a screen of 880 extracts from plants and fungi for antiplasmodial, antitrypanosomal, and leishmanicidal activity, an ethyl acetate extract of the mushroom Ganoderma lucidum showed antiplasmodial activity with 79% inhibition at 4.9 microg/mL. HPLC-based activity profiling and subsequent isolation of the antiplasmodial compounds yielded seven lanostanes (1-7), of which three (2, 3, and 7) were new. A new benzofuran derivative (8) of the farnesyl hydroquinone ganomycin B was also identified. The structures and relative configurations of the new compounds were elucidated by comprehensive spectroscopic analysis and by comparison of their NMR data with those of related compounds. The lanostanes exhibited in vitro antiplasmodial activity with IC(50) values from 6 to greater than 20 microM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384295     DOI: 10.1021/np100031c

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Positive GABA(A) receptor modulators from Acorus calamus and structural analysis of (+)-dioxosarcoguaiacol by 1D and 2D NMR and molecular modeling.

Authors:  Janine Zaugg; Eva Eickmeier; Samad Nejad Ebrahimi; Igor Baburin; Steffen Hering; Matthias Hamburger
Journal:  J Nat Prod       Date:  2011-05-12       Impact factor: 4.050

Review 2.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

Review 3.  Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification.

Authors:  Protus Arrey Tarkang; Regina Appiah-Opong; Michael F Ofori; Lawrence S Ayong; Alexander K Nyarko
Journal:  Biomark Res       Date:  2016-12-13

Review 4.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

5.  Meroterpenoids From Ganoderma lucidum Mushrooms and Their Biological Roles in Insulin Resistance and Triple-Negative Breast Cancer.

Authors:  Jiao-Jiao Zhang; Dai-Wei Wang; Dan Cai; Qing Lu; Yong-Xian Cheng
Journal:  Front Chem       Date:  2021-11-03       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.